Stapokibart plus glucocorticoids achieves disease control in elderly bullous pemphigoid patients
Trial shows stapokibart helps elderly bullous pemphigoid patients
In a single-center, retrospective, uncontrolled case series of 15 elderly patients with moderate-to-severe bullous pemphigoid, all achieved …
A small study found that adding stapokibart to standard therapy helped elderly patients with severe bullous pemphigoid control their skin di…
Stapokibart shows nasal symptom reduction in pediatric seasonal allergic rhinitis case series
Could a new drug help teens breathe easier during allergy season?
A retrospective case series of 20 pediatric patients with moderate-to-severe seasonal allergic rhinitis found that all patients demonstrated…
Twenty young patients with moderate-to-severe seasonal allergic rhinitis took stapokibart for one month. Every single person saw a significa…